A BILL 
To amend the Public Health Service Act to authorize grants 
to eligible entities to develop strategic response plans 
with respect to the opioid crisis, and to require health 
care practitioners prescribing an opioid for certain pa-
tients to also prescribe an opioid overdose reversal drug, 
and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Preventing Overdoses 
4
and Saving Lives Act of 2021’’. 
5
04:35 Sep 11, 2021
H5224
2 
•HR 5224 IH
SEC. 
2. 
STATE 
DEMONSTRATION 
GRANTS 
FOR 
COM-
1
PREHENSIVE OPIOID ABUSE DATA. 
2
Title III of the Public Health Service Act (42 U.S.C. 
3
241 et seq.) is amended by inserting after section 317U 
4
of such Act (42 U.S.C. 247b–23) the following: 
5
‘‘SEC. 317V. STATE DEMONSTRATION GRANTS FOR COM-
6
PREHENSIVE OPIOID ABUSE DATA. 
7
‘‘(a) IN GENERAL.—The Secretary, in conjunction 
8
with the Director of the Centers for Disease Control and 
9
Prevention, may award grants to eligible entities— 
10
‘‘(1) to conduct research and develop a strategic 
11
response plan with respect to the opioid crisis; and 
12
‘‘(2) to establish and implement a co-pre-
13
scribing program. 
14
‘‘(b) AMOUNT OF GRANTS.— 
15
‘‘(1) IN GENERAL.—The Secretary shall deter-
16
mine the amount of each grant awarded under this 
17
section on an annual basis. In allocating such 
18
amounts across grantees for a fiscal year, the Sec-
19
retary shall award— 
20
‘‘(A) a minimum amount to each grantee 
21
in accordance with paragraph (2); and 
22
‘‘(B) an additional amount to each grantee 
23
in accordance with paragraph (3). 
24
‘‘(2) 
MINIMUM
AMOUNT.—The 
Secretary 
25
shall— 
26
04:35 Sep 11, 2021
H5224
3 
•HR 5224 IH
‘‘(A) determine the basis for determining 
1
the minimum amount of a grant under para-
2
graph (1)(A); and 
3
‘‘(B) apply such basis consistently across 
4
all grantees under this section. 
5
‘‘(3) ADDITIONAL AMOUNT.—In allocating addi-
6
tional amounts across all grantees under this section 
7
for a fiscal year, the Secretary shall give priority in 
8
setting such amounts to grantees with the highest 
9
opioid dispensing rates as determined by the Centers 
10
for Disease Control and Prevention. 
11
‘‘(c) PRIORITY IN SELECTION.—In selecting grantees 
12
under this section, the Secretary shall give priority to eligi-
13
ble entities with the highest opioid dispensing rates as de-
14
termined by the Centers for Disease Control and Preven-
15
tion. 
16
‘‘(d) ALLOCATION OF FUNDS BY A GRANTEE.—A 
17
grantee under this section shall allocate the funds received 
18
through the grant as follows: 
19
‘‘(1) Not more than 80 percent of the funds re-
20
ceived through the grant shall be used to conduct re-
21
search and develop a strategic plan in accordance 
22
with subsection (e). 
23
04:35 Sep 11, 2021
H5224
4 
•HR 5224 IH
‘‘(2) At least 20 percent of the grant shall be 
1
used by the grantee to administer a co-prescribing 
2
program in accordance with subsection (f). 
3
‘‘(e) RESEARCH; STRATEGIC PLAN.— 
4
‘‘(1) IN GENERAL.—Subject to subsection (d), a 
5
grantee under this section shall use the grant 
6
funds— 
7
‘‘(A) to conduct research on the impacts of 
8
the opioid crisis within the jurisdiction of the 
9
grantee; and 
10
‘‘(B) to develop a strategic plan to respond 
11
to the opioid crisis within such jurisdiction. 
12
‘‘(2) STRATEGIC PLAN CONTENTS.—A strategic 
13
plan required by paragraph (1)(B) shall include 
14
plans for— 
15
‘‘(A) increasing public awareness about the 
16
opioid crisis within the jurisdiction of the grant-
17
ee; 
18
‘‘(B) full-spectrum prevention within such 
19
jurisdiction; 
20
‘‘(C) intervention within such jurisdiction; 
21
‘‘(D) treatment and recovery within such 
22
jurisdiction; and 
23
‘‘(E) coordinating with law enforcement 
24
within such jurisdiction. 
25
04:35 Sep 11, 2021
H5224
5 
•HR 5224 IH
‘‘(f) CO-PRESCRIBING PROGRAM.— 
1
‘‘(1) IN GENERAL.—Subject to subsection (d), a 
2
grantee under this section shall use funds received 
3
through the grant to carry out a co-prescribing pro-
4
gram under which the grantee requires— 
5
‘‘(A) health care practitioners in the juris-
6
diction of the grantee who prescribe an opioid 
7
for any patient to also prescribe an opioid over-
8
dose reversal drug for such patient if— 
9
‘‘(i) the opioid dosage prescribed is 
10
equal to or in excess of 50 morphine milli-
11
gram equivalents per day; 
12
‘‘(ii) the practitioner prescribes a 
13
benzodiazepine for the patient or knows or 
14
reasonably should know a benzodiazepine 
15
has been prescribed for the patient in the 
16
past; 
17
‘‘(iii) the practitioner prescribes medi-
18
cation-assisted treatment for the patient or 
19
knows or reasonably should know medica-
20
tion assisted treatment has been prescribed 
21
for the patient in the past; or 
22
‘‘(iv) the practitioner knows or rea-
23
sonably should know the patient has a his-
24
tory of substance use disorder; 
25
04:35 Sep 11, 2021
H5224
6 
•HR 5224 IH
‘‘(B) such health care practitioners to com-
1
plete continuing education on opioid pre-
2
scribing; and 
3
‘‘(C) coroners in the jurisdiction of the 
4
grantee to complete continuing education on 
5
recognizing fatalities attributable to an opioid 
6
overdose. 
7
‘‘(2) WAIVER.—If the laws, regulations, or or-
8
ders of an applicant for a grant under this section 
9
conflict in any respect with the requirements of sub-
10
paragraph (A), (B), or (C) of paragraph (1), the 
11
Secretary shall waive such requirements to the ex-
12
tent necessary to allow the grantee to carry out a co- 
13
prescribing program under this section. 
14
‘‘(g) SUPPLEMENT, NOT SUPPLANT.—Grant funds 
15
under this section shall be used to supplement, not sup-
16
plant, funding from other sources for the activities funded 
17
through the grant. 
18
‘‘(h) APPLICATION.—To seek a grant under this sec-
19
tion, an eligible entity shall submit an application at such 
20
time, in such manner, and containing such information 
21
and assurances as the Secretary may require. 
22
‘‘(i) REPORTING.—Not later than the end of each of 
23
fiscal years 2024 and 2026, a grantee under this section 
24
shall submit to the Secretary, the Director of the Centers 
25
04:35 Sep 11, 2021
H5224
7 
•HR 5224 IH
for Disease Control and Prevention, and the appropriate 
1
congressional committees, and make publicly available, a 
2
report on the activities funded through the grant for each 
3
fiscal year covered by the report, including— 
4
‘‘(1) the allocation of funds for activities under 
5
subsection (e) versus activities under subsection (f); 
6
‘‘(2) a description of the research conducted by 
7
the grantee under subsection (e)(1)(A), including the 
8
results of such research; 
9
‘‘(3) an up-to-date version of the strategic plan 
10
developed under subsection (e)(1)(B); and 
11
‘‘(4) a description of the co-prescribing program 
12
under subsection (f), including an analysis of the ef-
13
fectiveness of the program. 
14
‘‘(j) DEFINITIONS.—In this section: 
15
‘‘(1) APPROPRIATE
CONGRESSIONAL
COMMIT-
16
TEES.—The term ‘appropriate congressional com-
17
mittees’ means the Committee on Energy and Com-
18
merce of the House of Representatives and the Com-
19
mittee on Housing, Education, Labor, and Pensions 
20
of the Senate. 
21
‘‘(2) ELIGIBLE ENTITY.—The term ‘eligible en-
22
tity’ means any State, any Indian Tribe, the District 
23
of Columbia, or any territory of the United States. 
24
04:35 Sep 11, 2021
H5224
8 
•HR 5224 IH
‘‘(3) INDIAN TRIBE.—The term ‘Indian Tribe’ 
1
has the meaning given to such term in section 4 of 
2
the Indian Self-Determination and Education Assist-
3
ance Act. 
4
‘‘(4) OPIOID OVERDOSE REVERSAL DRUG.—The 
5
term ‘opioid overdose reversal drug’ means— 
6
‘‘(A) naloxone; or 
7
‘‘(B) any other emergency opioid antago-
8
nist approved by the Food and Drug Adminis-
9
tration to treat an opioid overdose. 
10
‘‘(k) AUTHORIZATION
OF
APPROPRIATIONS.—To 
11
carry out this section, there are authorized to be appro-
12
priated such sums as may be necessary for each of fiscal 
13
years 2022 through 2026.’’. 
14
Æ 
04:35 Sep 11, 2021
H5224
